These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7430338)

  • 21. Evaluation of the lysostaphin-susceptibility test for the classification of staphylococci.
    Heddaeus H; Heczko PB; Pulverer G
    J Med Microbiol; 1979 Feb; 12(1):9-15. PubMed ID: 430548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
    Shah A; Mond J; Walsh S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staphylococcus aureus mutants with increased lysostaphin resistance.
    Gründling A; Missiakas DM; Schneewind O
    J Bacteriol; 2006 Sep; 188(17):6286-97. PubMed ID: 16923896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonistic activities of coagulase-positive staphylococci.
    Balusek J; Hájek V
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(2):147-54. PubMed ID: 4020118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of lysostaphin to remove cell-adherent staphylococci during in vitro assays of phagocyte function.
    Easmon CS; Lanyon H; Cole PJ
    Br J Exp Pathol; 1978 Aug; 59(4):381-5. PubMed ID: 708586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The identification of staphylococci in clinical and food microbiology laboratories.
    Sperber WH
    CRC Crit Rev Clin Lab Sci; 1976; 7(2):121-84. PubMed ID: 797525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
    Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
    [No Abstract]   [Full Text] [Related]  

  • 28. Facile penetration of the Staphylococcus aureus capsule by lysostaphin.
    King BF; Biel ML; Wilkinson BJ
    Infect Immun; 1980 Sep; 29(3):892-6. PubMed ID: 7429637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic.
    Oldham ER; Daley MJ
    J Dairy Sci; 1991 Dec; 74(12):4175-82. PubMed ID: 1787188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of methods for routine separation of coagulase-negative staphylococci from micrococci isolated from sheep.
    de la Fuente R; Almazan J; Gomez-Lucia E; Freney J; Suarez G
    Comp Immunol Microbiol Infect Dis; 1986; 9(4):347-53. PubMed ID: 3802762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysostaphin lysis procedure for detection of Staphylococcus aureus by the firefly bioluminescent ATP method.
    Tuncan EU; Martin SE
    Appl Environ Microbiol; 1987 Jan; 53(1):88-91. PubMed ID: 3827251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of cloxacillin on staphylococci phagocytosed by bovine neutrophils.
    Craven N; Anderson JC
    Res Vet Sci; 1980 Jul; 29(1):57-62. PubMed ID: 7455355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Staphylococcus aureus with a fluorescence in situ hybridization that does not require lysostaphin.
    Lawson TS; Connally RE; Iredell JR; Vemulpad S; Piper JA
    J Clin Lab Anal; 2011; 25(2):142-7. PubMed ID: 21438009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-yield production of active recombinant S. simulans lysostaphin expressed in E. coli in a laboratory bioreactor.
    Duman-Özdamar ZE; Ünlü A; Ünal H; Woodley JM; Bi Nay B
    Protein Expr Purif; 2021 Jan; 177():105753. PubMed ID: 32950627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing Staphylococcus aureus resistance to lysostaphin using CRISPR-dCas9.
    Wu X; Zha J; Koffas MAG; Dordick JS
    Biotechnol Bioeng; 2019 Dec; 116(12):3149-3159. PubMed ID: 31433061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of BiTek agar on lysostaphin susceptibility of staphylococci.
    Langlois BE; Dawson K; Akers K
    J Clin Microbiol; 1990 Nov; 28(11):2568-9. PubMed ID: 2254432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model.
    Kokai-Kun JF; Walsh SM; Chanturiya T; Mond JJ
    Antimicrob Agents Chemother; 2003 May; 47(5):1589-97. PubMed ID: 12709327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
    Polak J; Della Latta P; Blackburn P
    Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the LightCycler Staphylococcus M GRADE kits on positive blood cultures that contained gram-positive cocci in clusters.
    Shrestha NK; Tuohy MJ; Padmanabhan RA; Hall GS; Procop GW
    J Clin Microbiol; 2005 Dec; 43(12):6144-6. PubMed ID: 16333115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.